ASHPOfficial

This podcast episode discusses ASHP and other healthcare organizations releasing a series of policy and marketplace recommendations to address significant challenges in our nation's drug supply chain that have been exacerbated by the COVID-19 pandemic.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This case presentation from the Midyear Clinical Meeting 2020 shares the methods by which two rural community hospitals in a newly formed healthcare-system worked together to modify many aspect of everyday operations to respond to their health-system's COVID-19 response, including medication management, infection prevention, and treatment protocol development.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists play an important role in emerging areas, including gene-based and cell-based therapies. Excerpts from this 2020 Midyear Clinical Meeting Presentation share how pharmacists can recommend processes for safe handling of cell- and gene-based therapies, meet standards for storage and preparation of these therapies, and prepare their departments to provide these therapies as more become available.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Brush up on your pediatric medication safety with this excerpt from Section of Clinical Specialists and Scientists’ presentation from the 2020 Midyear Clinical Meeting. Our content matter experts review the purpose of the KIDs list, teach how to assess if a medication is safe to use in pediatrics, and explain why a medication may not be safe to use in the pediatric population. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses the need for Medicare coverage of pharmacy services related to ordering oral antivirals for COVID-19. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

For new preceptors, staying on top of clinical responsibilities and all of the learning goals and objectives of your residents can be difficult. Tools that help that transition can make a world of difference. In this episode of Educator Essentials, we discuss using a weekly roadmap to help preceptors and their residents on the track to success.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The COVID-19 pandemic has presented several challenges for pharmacist-run anticoagulation clinics. In this 2020 Midyear Clinical Meeting presentation, Yale New Haven Pharmacists share their approach to adjusting clinic in-person visit workflows to continue to provide high-quality patient care and monitoring while adequately protecting patients and staff. They describe their remote methods to monitor anticoagulation therapy and identify their successes with intradepartmental communication.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Planned in cooperation with Section of Pharmacy Practice Leaders, this podcast episode helps the listener identify the five principles that are required for a high-performing team, summarizes ways teamwork can positively impact individuals and the organization, and identifies strategies to overcome challenges that may arise within a team.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this feature from the Section of Ambulatory Care Practitioners’ presentation at the 2020 Midyear Clinical Meeting, our content matter experts review the most appropriate continuous glucose monitor based on patient-specific factors and design a patient-centered diabetes treatment plan using continuous glucose monitoring data.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Drs. Janet Silvester, Julie Dagam, and Jamie Kalus discuss the benefits and impact of standardizing pharmacy residency programs within multi-entity health systems, with respect to the perspectives of both the accrediting body and the residency programs. They share areas and example policies that would benefit from standardization, as well as go over the challenges faced during the alignment process.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.